Hesperidin Suppresses Ovalbumin-Induced Airway Inflammation in a Mouse Allergic Asthma Model

被引:0
作者
Dajun Wei
Xinxin Ci
Xiao Chu
Miaomiao Wei
Shucheng Hua
Xuming Deng
机构
[1] The First Hospital of Jilin University,Key Laboratory of Zoonosis Research, Ministry of Education, Institute of Zoonosis, College of Animal Science and Veterinary Medicine
[2] Jilin University,Medical Department
[3] Beihua University,undefined
来源
Inflammation | 2012年 / 35卷
关键词
hesperidin; allergic asthma; airway inflammation; airway hyperresponsiveness;
D O I
暂无
中图分类号
学科分类号
摘要
Hesperidin, a flavanone glycoside comprised of the flavanone hesperetin and the disaccharide rutinose, is a plentiful and inexpensive by-product of citrus cultivation. It has been reported to exert a wide range of pharmacological effects that include antioxidant, anti-inflammatory, and anticarcinogenic properties. In this study, we attempt to determine whether hesperidin inhibits inflammatory mediators in the mouse allergic asthma model. Mice were sensitized and challenged by ovalbumin (OVA) to induce chronic airway inflammation and airway remodeling. The administration of hesperidin significantly decreased the number of infiltrating inflammatory cells and Th2 cytokines in bronchoalveolar lavage (BAL) fluid compared with the OVA-induced group of mice. In addition, hesperidin reduced OVA-specific IgE levels in serum. Hesperidin markedly alleviated the OVA-induced airway hyperresponsiveness (AHR) to inhaled methacholine. Based on lung histopathological studies using hematoxylin and eosin and alcian blue-periodic acid-Schiff staining, hesperidin inhibited inflammatory cell infiltration and mucus hypersecretion compared with the OVA-induced group of mice. These findings provide new insight into the immunopharmacological role of hesperidin in terms of its effects in a murine model of asthma.
引用
收藏
页码:114 / 121
页数:7
相关论文
共 127 条
[1]  
Bochner BS(2004)Advances in mechanisms of allergy The Journal of Allergy and Clinical Immunology 113 868-875
[2]  
Busse WW(2005)Allergy and asthma The Journal of Allergy and Clinical Immunology 115 953-959
[3]  
Bochner BS(2001)Asthma The New England Journal of Medicine 344 350-362
[4]  
Busse WW(1993)Calhoun William WF, Sedgwick JD. Mechanism of airway inflammation in asthma The American Review of Respiratory Disease 147 S20-S24
[5]  
Busse WW(2005)Cytokines, allergy, and asthma Current Opinion in Allergy and Clinical Immunology 5 161-166
[6]  
Lemanske RF(1999)Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production Journal of Clinical Investigation 103 779-788
[7]  
Busse WW(2003)Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13 Molecular Therapy 7 155-162
[8]  
Ngoc PL(2008)IL-5 and eosinophilia Current Opinion in Immunology 20 288-294
[9]  
Gold DR(2001)Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma The Journal of Allergy and Clinical Immunology 108 184-190
[10]  
Tzianabos AO(2004)Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma American Journal of Respiratory and Critical Care Medicine 170 583-593